Deutsche Bank Initiates Coverage On CarLotz with Hold Rating, Announces Price Target of $7
Deutsche Bank analyst Emmanuel Rosner initiates coverage on CarLotz (NASDAQ:LOTZ) with a Hold rating and announces Price Target of $7.
85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
54 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
William Blair Downgrades CarLotz to Market Perform
William Blair analyst Sharon Zackfia downgrades CarLotz (NASDAQ:LOTZ) from Outperform to Market Perform.
CarLotz Q2 EPS $(0.06) Beats $(0.20) Estimate, Sales $50.77M Beat $44.92M Estimate
CarLotz (NASDAQ:LOTZ) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.20) by 70 percent. The company reported quarterly sales of $50.77 million which beat the analyst
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
